Ascentage Pharma Group International (AAPG) Equity Average (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Historic Equity Average for Ascentage Pharma Group International (AAPG) over the last 2 years, with Q4 2024 value amounting to $24.0 million.

• Ascentage Pharma Group International's Equity Average fell 2867.79% to $24.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $24.0 million, marking a year-over-year decrease of 2867.79%. This contributed to the annual value of $23.8 million for FY2024, which is 3288.86% down from last year.
• Per Ascentage Pharma Group International's latest filing, its Equity Average stood at $24.0 million for Q4 2024, which was down 2867.79% from $33.6 million recorded in Q4 2023.
• Ascentage Pharma Group International's 5-year Equity Average high stood at $33.6 million for Q4 2023, and its period low was $24.0 million during Q4 2024.

Peer Comparison